MYGN logo

Myriad Genetics (MYGN) Total Assets

Annual Total Assets

$1.15 B
-$52.20 M-4.35%

01 December 2023

MYGN Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$1.08 B
-$3.80 M-0.35%

01 September 2024

MYGN Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MYGN Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.3%-5.9%
3 y3 years-19.2%-19.1%
5 y5 years-26.6%-32.0%

MYGN Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-19.2%at low-19.1%at low
5 y5 years-26.6%at low-32.0%at low
alltimeall time-26.6%+2039.0%-32.0%+1917.3%

Myriad Genetics Total Assets History

DateAnnualQuarterly
Sept 2024
-
$1.08 B(-0.4%)
June 2024
-
$1.09 B(-2.3%)
Mar 2024
-
$1.11 B(-3.1%)
Dec 2023
$1.15 B(-4.4%)
$1.15 B(-0.2%)
Sept 2023
-
$1.15 B(-3.2%)
June 2023
-
$1.19 B(+1.5%)
Mar 2023
-
$1.17 B(-2.5%)
Dec 2022
$1.20 B(-9.2%)
$1.20 B(-1.1%)
Sept 2022
-
$1.21 B(+0.1%)
June 2022
-
$1.21 B(-3.6%)
Mar 2022
-
$1.26 B(-4.9%)
Dec 2021
$1.32 B(-6.9%)
$1.32 B(-1.1%)
Sept 2021
-
$1.34 B(-1.8%)
June 2021
-
$1.36 B(+1.8%)
Mar 2021
-
$1.34 B(-7.4%)
Dec 2020
$1.42 B(+1.0%)
-
Sept 2020
-
$1.44 B(+2.8%)
June 2020
$1.40 B(-10.1%)
$1.40 B(-2.9%)
Mar 2020
-
$1.45 B(-8.3%)
Dec 2019
-
$1.58 B(-0.8%)
Sept 2019
-
$1.59 B(+1.8%)
June 2019
$1.56 B(+33.0%)
$1.56 B(+0.3%)
Mar 2019
-
$1.56 B(+0.0%)
Dec 2018
-
$1.56 B(-1.1%)
Sept 2018
-
$1.57 B(+33.9%)
June 2018
$1.18 B(-2.8%)
$1.18 B(-3.5%)
Mar 2018
-
$1.22 B(-0.8%)
Dec 2017
-
$1.23 B(+0.0%)
Sept 2017
-
$1.23 B(+1.6%)
June 2017
$1.21 B(+37.3%)
$1.21 B(-4.6%)
Mar 2017
-
$1.27 B(-0.7%)
Dec 2016
-
$1.28 B(+0.4%)
Sept 2016
-
$1.27 B(+44.3%)
June 2016
$880.50 M(+14.9%)
$880.50 M(+1.4%)
Mar 2016
-
$868.20 M(-0.4%)
Dec 2015
-
$871.70 M(+10.8%)
Sept 2015
-
$787.00 M(+2.7%)
June 2015
$766.20 M(-7.0%)
$766.20 M(-1.6%)
Mar 2015
-
$779.05 M(-0.4%)
Dec 2014
-
$781.85 M(-3.4%)
Sept 2014
-
$809.01 M(-1.8%)
June 2014
$823.80 M(+2.5%)
$823.80 M(+0.9%)
Mar 2014
-
$816.43 M(+7.9%)
Dec 2013
-
$756.68 M(-3.2%)
Sept 2013
-
$781.66 M(-2.8%)
June 2013
$803.82 M(+16.4%)
$803.82 M(+10.3%)
Mar 2013
-
$729.03 M(+1.6%)
Dec 2012
-
$717.75 M(+2.1%)
Sept 2012
-
$703.06 M(+1.8%)
June 2012
$690.63 M(+13.1%)
$690.63 M(-1.2%)
Mar 2012
-
$699.25 M(+5.7%)
Dec 2011
-
$661.26 M(+6.7%)
Sept 2011
-
$619.74 M(+1.5%)
June 2011
$610.83 M(+2.9%)
$610.83 M(+9.6%)
Mar 2011
-
$557.28 M(-6.1%)
Dec 2010
-
$593.61 M(-2.8%)
Sept 2010
-
$610.84 M(+2.9%)
June 2010
$593.85 M
$593.85 M(+0.7%)
DateAnnualQuarterly
Mar 2010
-
$589.56 M(+9.2%)
Dec 2009
-
$540.04 M(+9.3%)
Sept 2009
-
$494.13 M(+5.9%)
June 2009
$466.39 M(-6.6%)
$466.39 M(-24.8%)
Mar 2009
-
$620.43 M(+8.2%)
Dec 2008
-
$573.57 M(+8.0%)
Sept 2008
-
$531.23 M(+6.4%)
June 2008
$499.34 M(+33.0%)
$499.34 M(+27.7%)
Mar 2008
-
$390.96 M(+1.7%)
Dec 2007
-
$384.36 M(+2.9%)
Sept 2007
-
$373.37 M(-0.6%)
June 2007
$375.54 M(+35.8%)
$375.54 M(+3.7%)
Mar 2007
-
$362.15 M(+38.1%)
Dec 2006
-
$262.32 M(-0.2%)
Sept 2006
-
$262.82 M(-5.0%)
June 2006
$276.60 M(+74.0%)
$276.60 M(-0.6%)
Mar 2006
-
$278.29 M(-2.4%)
Dec 2005
-
$285.23 M(+90.1%)
Sept 2005
-
$150.03 M(-5.6%)
June 2005
$158.96 M(-15.6%)
$158.96 M(-1.0%)
Mar 2005
-
$160.58 M(-6.3%)
Dec 2004
-
$171.36 M(-3.4%)
Sept 2004
-
$177.48 M(-5.8%)
June 2004
$188.36 M(+3.0%)
$188.36 M(+27.0%)
Mar 2004
-
$148.33 M(-5.5%)
Dec 2003
-
$157.00 M(-5.4%)
Sept 2003
-
$165.98 M(-9.2%)
June 2003
$182.82 M(+16.2%)
$182.82 M(-0.1%)
Mar 2003
-
$182.92 M(-7.2%)
Dec 2002
-
$197.11 M(+40.7%)
Sept 2002
-
$140.10 M(-11.0%)
June 2002
$157.39 M(-8.6%)
$157.39 M(+2.4%)
Mar 2002
-
$153.67 M(-3.3%)
Dec 2001
-
$158.92 M(-1.4%)
Sept 2001
-
$161.24 M(-6.3%)
June 2001
$172.15 M(+61.8%)
$172.15 M(+6.1%)
Mar 2001
-
$162.25 M(+0.5%)
Dec 2000
-
$161.48 M(+32.1%)
Sept 2000
-
$122.23 M(+14.9%)
June 2000
$106.38 M(+98.5%)
$106.38 M(+36.6%)
Mar 2000
-
$77.87 M(+5.4%)
Dec 1999
-
$73.90 M(+13.5%)
Sept 1999
-
$65.10 M(+21.5%)
June 1999
$53.60 M(-20.5%)
$53.60 M(-4.6%)
Mar 1999
-
$56.20 M(-4.9%)
Dec 1998
-
$59.10 M(-5.9%)
Sept 1998
-
$62.80 M(-6.8%)
June 1998
$67.40 M(-11.4%)
$67.40 M(-3.0%)
Mar 1998
-
$69.50 M(-4.3%)
Dec 1997
-
$72.60 M(-2.7%)
Sept 1997
-
$74.60 M(-2.0%)
June 1997
$76.10 M(-4.4%)
$76.10 M(+8.4%)
Mar 1997
-
$70.20 M(-5.0%)
Dec 1996
-
$73.90 M(-4.8%)
Sept 1996
-
$77.60 M(-2.5%)
June 1996
$79.60 M
$79.60 M(-1.8%)
Mar 1996
-
$81.10 M(+3.0%)
Dec 1995
-
$78.70 M

FAQ

  • What is Myriad Genetics annual total assets?
  • What is the all time high annual total assets for Myriad Genetics?
  • What is Myriad Genetics annual total assets year-on-year change?
  • What is Myriad Genetics quarterly total assets?
  • What is the all time high quarterly total assets for Myriad Genetics?
  • What is Myriad Genetics quarterly total assets year-on-year change?

What is Myriad Genetics annual total assets?

The current annual total assets of MYGN is $1.15 B

What is the all time high annual total assets for Myriad Genetics?

Myriad Genetics all-time high annual total assets is $1.56 B

What is Myriad Genetics annual total assets year-on-year change?

Over the past year, MYGN annual total assets has changed by -$52.20 M (-4.35%)

What is Myriad Genetics quarterly total assets?

The current quarterly total assets of MYGN is $1.08 B

What is the all time high quarterly total assets for Myriad Genetics?

Myriad Genetics all-time high quarterly total assets is $1.59 B

What is Myriad Genetics quarterly total assets year-on-year change?

Over the past year, MYGN quarterly total assets has changed by -$67.80 M (-5.90%)